(c) 2024 PillSync.com

modafinil tablet

1 INDICATIONS AND USAGE Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). Limitations of Use In OSA, modafinil tablets are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction. If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating and during treatment with modafinil tablets for excessive sleepiness. Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). (1) Limitations of Use In OSA, modafinil tablets are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction.

alembic pharmaceuticals limited


6 years ago OVAL WHITE L234 modafinil tablet

OVAL WHITE L234

6 years ago OVAL WHITE L234 modafinil tablet

L234 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied

MODAFINIL Tablets USP 100 mg: white to off-white color, round shape, biconvex, uncoated tablets with ‘L233’ debossed on one side and plain on other side. NDC 46708-385-30 bottle of 30 tablets NDC 46708-385-60 bottle of 60 tablets NDC 46708-385-90 bottle of 90 tablets NDC 46708-385-91 bottle of 1000 tablets NDC 46708-385-10 100 (10 x 10) unit dose blisters tablets 200 mg: white to off-white color, round shape, biconvex, uncoated tablets with ‘L234’ debossed on one side and breakline on other side. NDC 46708-386-30 bottle of 30 tablets NDC 46708-386-60 bottle of 60 tablets NDC 46708-386-90 bottle of 90 tablets NDC 46708-386-91 bottle of 1000 tablets NDC 46708-386-10 100 (10 x 10) unit dose blisters tablets 16.2 Storage Store at 20°-25°C (68°-77°F). [See USP Controlled Room Temperature]


More pills like OVAL L234












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site